Acute Porphyria Drug Database

J07AJ52 - Pertussis, Purified Antigen, Combinations with Toxoids
Propably not porphyrinogenic
PNP

Side effects
Common adverse reactions of the vaccine that can be confused with an acute porphyric attack are nausea, vomiting, diarrhea and abdominal pain. These side effects may potentially be porphyrinogenic if leading to a decrease in carbohydrate intake.
Rationale
Based on the pharmacokinetics of the pertussis combination vaccine there are no conceivable porphyrinogenic effects.
Chemical description
Antigens from Bordetella Pertussis and diphtheria and tetanus toxoids.
Therapeutic characteristics
The pertussis combination vaccine is indicated for booster vaccination against diphtheria, tetanus and pertussis in individuals from age four years and older. It is administered as a single dose by deep intramuscular injection
Metabolism and pharmacokinetics
The pertussis combination vaccine is not metabolized by the cytochrome P450 system.

References

  1. Scientific articles
  2. Decker MD, Edwards KM, Steinhoff MC, et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 1995 Sep;96(3 Pt 2):557-66. #1863
  3. Government bodies
  4. Norwegian Institute of Public Health. Vaksinasjonsveilederen. www.fhi.no (updated 13.10.2015) #1860
  5. Summary of Product Characteristics
  6. Norwegian medicines agency. Summary of Product Characteristics (SPC). Boostrix. #1864

Similar drugs
Explore alternative drugs in similar therapeutic classes J07A / J07AJ or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙